Patent Yard Sign in
Canadian application, no grantCanada

Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said

CA 2383523 A1 · Owner: Beisel, Gunther · Inventors: Beisel, Gunther

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to an orally administered agent containing stable uronic acid-containing polysaccharides cross-linked to each other and in the form of a sponge-like structure which dissolves poorly in water and/or gastrointestinal liquids or can be poorly resorbed. A method for the production and application of the said agent is also disclosed.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 5, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 5, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 5, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 5, 2000
GrantedNo grant recorded
Term endedSeptember 5, 2020
Patent numberCA 2383523 A1
Classification (IPC)A23L1/30 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedSep 5, 2000Term endedSep 5, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.